Trial · NCT01030952
Adverse events30
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 30
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal distension | Gastrointestinal disorders | Nateglinide | 0 | 51 | |
| other | Abdominal distension | Gastrointestinal disorders | Acarbose | 4 | 52 | |
| other | Frequency bowel movements | Gastrointestinal disorders | Nateglinide | 0 | 51 | |
| other | Frequency bowel movements | Gastrointestinal disorders | Acarbose | 2 | 52 | |
| other | Gastrointestinal flatulence | Gastrointestinal disorders | Nateglinide | 0 | 51 | |
| other | Gastrointestinal flatulence | Gastrointestinal disorders | Acarbose | 7 | 52 | |
| other | Hypoglycemia | Metabolism and nutrition disorders | Nateglinide | 3 | 51 | |
| other | Hypoglycemia | Metabolism and nutrition disorders | Acarbose | 0 | 52 | |
| other | Upper respiratory tract infection | Respiratory, thoracic and mediastinal disorders | Nateglinide | 0 | 51 | |
| other | Upper respiratory tract infection | Respiratory, thoracic and mediastinal disorders | Acarbose | 2 | 52 | |
| other | White blood cells count decrease | Investigations | Nateglinide | 0 | 51 | |
| other | White blood cells count decrease | Investigations | Acarbose | 1 | 52 | |
| other | White blood cells count increase | Investigations | Nateglinide | 1 | 51 | |
| other | White blood cells count increase | Investigations | Acarbose | 0 | 52 | |
| other | Diarrhoea | Gastrointestinal disorders | Nateglinide | 0 | 51 | |
| other | Diarrhoea | Gastrointestinal disorders | Acarbose | 1 | 52 | |
| other | Hepatic function abnormal | Hepatobiliary disorders | Nateglinide | 0 | 51 | |
| other | Hepatic function abnormal | Hepatobiliary disorders | Acarbose | 1 | 52 | |
| other | Bronchopneumonia | Infections and infestations | Nateglinide | 0 | 51 | |
| other | Bronchopneumonia | Infections and infestations | Acarbose | 1 | 52 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01030952/events